Tim Lautenschlaeger MD

Tim Lautenschlaeger MD
Clinical Inst HSCollege of Medicinelautenschlaeger.1@osu.edu
385G Wiseman Hall 400 W 12th Avenue Columbus Ohio 43210
Phone:614-247-6432Fax: 614-292-5275
  • Experimental Therapeutics

Current Publications

  • Schackert GIs there pseudoprogression in secondary glioblastomas?Int J Radiat Oncol Biol Phys 87 1094-9 12/1/2013
  • Lautenschlaeger T, Perry J, Peereboom D, Li B, Ibrahim A, Huebner A, Meng W, White J, Chakravarti AIn vitro study of combined cilengitide and radiation treatment in breast cancer cell lines.Radiat Oncol 8 246 10/23/2013
  • Meng W, Ye Z, Cui R, Perry J, Dedousi-Huebner V, Huebner A, Wang Y, Li B, Volinia S, Nakanishi H, Kim T, Suh SS, Ayers LW, Ross P, Croce C, Chakravarti A, Victor J, Lautenschlaeger TMicroRNA-31 predicts the presence of lymph node metastases and survival in patients with lung adenocarcinoma.Clin Cancer Res 19(19) 5423-33 10/1/2013
  • Lautenschlaeger T, George A, Klimowicz AC, Efstathiou JA, Wu CL, Sandler H, Shipley WU, Tester WJ, Hagan MP, Magliocco AM, Chakravarti ABladder preservation therapy for muscle-invading bladder cancers on Radiation Therapy Oncology Group trials 8802, 8903, 9506, and 9706: vascular endothelial growth factor B overexpression predicts for increased distant metastasis and shorter survival.Oncologist 18(6) 685-6 6/1/2013
  • Cottini F, Lautenschlaeger TPredictors of biomarkers guiding targeted therapeutic strategies in locally advanced lung cancer.Cancer J 19(3) 263-71 5/1/2013
  • Chakravarti A, Wang M, Robins HI, Lautenschlaeger T, Curran WJ, Brachman DG, Schultz CJ, Choucair A, Dolled-Filhart M, Christiansen J, Gustavson M, Molinaro A, Mischel P, Dicker AP, Bredel M, Mehta MRTOG 0211: a phase 1/2 study of radiation therapy with concurrent gefitinib for newly diagnosed glioblastoma patients.Int J Radiat Oncol Biol Phys 85(5) 1206-11 4/1/2013
  • Meng W, McElroy JP, Volinia S, Palatini J, Warner S, Ayers LW, Palanichamy K, Chakravarti A, Lautenschlaeger TComparison of microRNA deep sequencing of matched formalin-fixed paraffin-embedded and fresh frozen cancer tissues.PLoS One 8(5) e64393 1/1/2013

The Ohio State University Comprehensive Cancer Center – Arthur G. James Cancer Hospital and Richard J. Solove Research Institute (OSUCCC – James) 300 W. 10th Ave. Columbus, OH 43210 Phone: 1-800-293-5066 | Email: jamesline@osumc.edu